The Vertical Group

The Vertical Group

The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.

The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology. The principals of the vertical group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's most successful companies. The Vertical Group is the successor to the venture capital division of F. Eberstadt & Co., and has been an independent firm since 1988.

The Vertical Group has made 51 investments as of 2018. Their most recent investment was on Mar 5, 2018, when Biorez raised $1.5M. The Vertical Group has had 14 exits. The Vertical Group's most notable exits include Silk Road Medical, OncoMed Pharmaceuticals, and TetraLogic Pharmaceuticals. The Vertical Group has raised a total of $10M in a single venture fund, Vertical Fund II. This fund was announced on Jan 23, 2006 and raised a total of $10M.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
ViaCyte

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.

Omada Health is a San Francisco-based company.

Silk Road Medical is a Sunnyvale, California-based healthcare company.

A life sciences company focused on protein research using nanoproteomics

PhotoThera is a biotechnology company.

Outset Medical is a San Jose, California-based medical device company.

Tepha is a healthcare company.

Galil Medical is a healthcare company.

11 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Benton Morgan

Employee

Daniel Cho

Employee

Frank Caputo

Employee

Kaira Nithin Goud

Employee

Palmer Emmitt

Investor

Tony Chou

Employee

Vincent Novak

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.